Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Haneda

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Disease|September 22, 2017
The detectability of the pretreatment EGFR T790M mutations in lung adenocarcinoma using CAST-PCR and digital PCRTsutomu Tatematsu, Katsuhiro Okuda, Ayumi Suzuki, et al.
Oncology Letters|July 12, 2017
Exon 7 splicing variant of estrogen receptor α is associated with pathological invasiveness in smoking-independent lung adenocarcinomaAyumi Suzuki, Katsuhiro Okuda, Motoki Yano, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 30, 2022
Preoperative percutaneous needle indigo carmine and lipiodol mixture marking in lung segmentectomyTakuya Matsui, Yusuke Takahashi, Takeo Nakada, et al.
Clinical Lung Cancer|January 17, 2025
Comparison of Sublobar Resection and Proton Therapy for Early-Stage Non-small Cell Lung CancerTadashi Sakane, Koichiro Nakajima, Hiromitsu Iwata, et al.
Oncotarget|May 15, 2018
Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesotheliomaTakuya Watanabe, Katsuhiro Okuda, Takayuki Murase, et al.
Japanese Journal of Clinical Oncology|February 2, 2006
A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinomaHiroshi Haneda, Hidefumi Sasaki, Neal Lindeman, et al.
Respiratory Investigation|July 21, 2023
Factors related to fixedness after transbronchial fiducial marker placement for image-guided proton therapy: A retrospective studyYusuke Yamaba, Misuzu Yoshihara, Osamu Takakuwa, et al.
Molecular and Clinical Oncology|February 2, 2018
S-1 vs. paclitaxel plus carboplatin as adjuvant chemotherapy for completely resected stage II/IIIA non-small-cell lung cancerKatsuhiro Okuda, Motoki Yano, Tsutomu Tatematsu, et al.
Journal of Thoracic Disease|March 14, 2019
Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leakTakuya Watanabe, Ichiro Fukai, Katsuhiro Okuda, et al.
International Journal of Cancer|July 9, 2005
EGFR and erbB2 mutation status in Japanese lung cancer patientsHidefumi Sasaki, Shigeki Shimizu, Katsuhiko Endo, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Disease|September 22, 2017
The detectability of the pretreatment EGFR T790M mutations in lung adenocarcinoma using CAST-PCR and digital PCRTsutomu Tatematsu, Katsuhiro Okuda, Ayumi Suzuki, et al.
Oncology Letters|July 12, 2017
Exon 7 splicing variant of estrogen receptor α is associated with pathological invasiveness in smoking-independent lung adenocarcinomaAyumi Suzuki, Katsuhiro Okuda, Motoki Yano, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 30, 2022
Preoperative percutaneous needle indigo carmine and lipiodol mixture marking in lung segmentectomyTakuya Matsui, Yusuke Takahashi, Takeo Nakada, et al.
Clinical Lung Cancer|January 17, 2025
Comparison of Sublobar Resection and Proton Therapy for Early-Stage Non-small Cell Lung CancerTadashi Sakane, Koichiro Nakajima, Hiromitsu Iwata, et al.
Oncotarget|May 15, 2018
Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesotheliomaTakuya Watanabe, Katsuhiro Okuda, Takayuki Murase, et al.
Japanese Journal of Clinical Oncology|February 2, 2006
A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinomaHiroshi Haneda, Hidefumi Sasaki, Neal Lindeman, et al.
Respiratory Investigation|July 21, 2023
Factors related to fixedness after transbronchial fiducial marker placement for image-guided proton therapy: A retrospective studyYusuke Yamaba, Misuzu Yoshihara, Osamu Takakuwa, et al.
Molecular and Clinical Oncology|February 2, 2018
S-1 vs. paclitaxel plus carboplatin as adjuvant chemotherapy for completely resected stage II/IIIA non-small-cell lung cancerKatsuhiro Okuda, Motoki Yano, Tsutomu Tatematsu, et al.
Journal of Thoracic Disease|March 14, 2019
Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leakTakuya Watanabe, Ichiro Fukai, Katsuhiro Okuda, et al.
International Journal of Cancer|July 9, 2005
EGFR and erbB2 mutation status in Japanese lung cancer patientsHidefumi Sasaki, Shigeki Shimizu, Katsuhiko Endo, et al.
Pageof 6